Medicare Part D Savings Under the Manufacturer Discount Program vs Coverage Gap Discounts

Rome BN, Garrett KR, Maini L - JAMA Network Open

  • Price, Value, and Access

Summary:

When comparing the Coverage Gap Discount (CGD) and the Manufacturer Discount Program (MDP) in Medicare Part D, Medicare would have received $34 billion from drug makers under the MDP, compared to $17 billion under the CGD based on 2022 data. Discounts in the MDP also increased substantially for high-cost specialty drugs, highlighting how this policy change will affect Medicare Part D spending going forward.

VIEW SOURCE

Recent Work from PORTAL

Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Pharmaceutical Industry Pay-Per-Click Advertising Strategies to Influence Public Opinions on Drug Pricing

Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics

  • Price, Value, and Access
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Coverage and Costs for Medications After Medicare Price Negotiation

Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine

  • Price, Value, and Access
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Methodological Divergence in Oncology HTA: Implications for International Harmonization and the Handling of Uncertainty

Chen NC, Bullement A, Zemplenyi AT, O'Bryant CL, Kaizer AM, Anderson KE, McQueen RB - PharmacoEconomics Open

  • Price, Value, and Access